Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer-Reference-Cited by-同舟云学术

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

Published:2012-07-06 Issue:4 Volume:14 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Kim Jisun,Han Wonshik,Moon Hyeong-Gon,Ahn Soo Kyung,Shin Hee-Chul,You Jee-Man,Han Sae-Won,Im Seock-Ah,Kim Tae-You,Koo Hye Ryoung,Chang Jung Min,Cho Nariya,Moon Woo Kyung,Noh Dong-Young

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3221.pdf

Reference15 articles.

1. Mousa NA, Crystal P, Wolfman WL, Bedaiwy MA, Casper RF: Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy. Menopause. 2008, 15: 875-884. 10.1097/gme.0b013e31816956c3.

2. Jeon JH, Kang JH, Kim Y, Lee HY, Choi KS, Jun JK, Oh DK, Lee CY, Ko K, Park EC: Reproductive and hormonal factors associated with fatty or dense breast patterns among korean women. Cancer Res Treat. 2011, 43: 42-48. 10.4143/crt.2011.43.1.42.

3. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, Visscher DW, Reynolds C, Frost MH, Hartmann LC: Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst. 2010, 102: 1716-1723. 10.1093/jnci/djq414.

4. Boyd NF: Tamoxifen, mammographic density, and breast cancer prevention. J Natl Cancer Inst. 2011, 103: 704-705. 10.1093/jnci/djr115.

5. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM: Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst. 2011, 103: 744-752. 10.1093/jnci/djr079.

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta‐analysis;Cancer;2024-09-05

2. Mammographic density changes after neoadjuvant chemotherapy in triple-negative breast cancer: Association with treatment and survival outcome;Clinical Imaging;2024-05

3. Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence;Cancer Medicine;2024-01

4. Mammographic Breast Density and Utility in Breast Cancer Screening and Clinical Decision-Making;Interdisciplinary Cancer Research;2024

5. Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study;International Journal of Surgery;2023-11-23